image
AxoGen, Inc. AXGN
Healthcare - Medical - Devices - NASDAQ - US
Watchlist
$ 16.39
-2.03 %
$ 746 M
Market Cap
-71.35
P/E
INCOME STATEMENT
187 M REVENUE
17.81%
Growth Rates
1Year 17.81%
3Years 13.73%
5Years 11.91%
7Years 17.54%
10Years 27.26%
-3.29 M OPERATING INCOME
84.68%
Growth Rates
1Year 84.68%
3Years 49.43%
5Years 36.33%
7Years 11.86%
10Years 10.35%
-9.96 M NET INCOME
54.12%
Growth Rates
1Year 54.12%
3Years 28.26%
5Years 19.31%
7Years 0.67%
10Years 5.59%
EFFICIENCY
Earnings Waterfall AxoGen, Inc.
image
Revenue 187 M
Cost Of Revenue 45.4 M
Gross Profit 142 M
Operating Expenses 145 M
Operating Income -3.29 M
Other Expenses 6.68 M
Net Income -9.96 M
200m200m180m180m160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m00(20m)(20m)187m(45m)142m(145m)(3m)(7m)(10m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Jun-2001 Jun-2000 Jun-1999 Jun-1998 Jun-1997 Jun-1996 Jun-1995 Jun-1994 Jun-1993 Jun-1992 Jun-1991 Jun-1990 Jun-1989 Jun-1988 Jun-1987
REVENUE
Revenue 187.3 159.0 138.6 127.4 112.3 106.7 83.9 60.4 41.1 27.3 16.8 10.9 7.7 4.8 91.3 K 24.9 72.7 K 0.1 0.1 0.4 1.1 7.2 6.9 15.9 14.6 12.3 12.9 12.3 13.1 14.1 10.7 9.2 8.1 8.0 6.8 6.4 5.8 4.7
GROSS PROFIT
Cost Of Revenue 45.4 31.1 24.1 22.9 21.6 17.3 12.9 9.3 6.5 4.8 3.4 2.4 2.0 2.4 0 0 0 0 0 0 0 5.5 5.2 10.5 8.6 7.3 8.4 6.9 7.0 7.5 6.1 5.3 4.5 4.7 3.8 3.3 2.6 4.0
Gross Profit 142.0 127.9 114.4 104.4 90.7 89.4 71.0 51.1 34.6 22.5 13.4 8.5 5.7 2.4 91.3 K 24.9 72.7 K 0.1 0.1 0.4 1.1 1.7 1.6 5.4 6.0 5.0 4.5 5.4 6.1 6.6 4.6 3.9 3.6 3.3 3.0 3.1 3.2 0.7
OPERATING INCOME
Operating Expenses 145.3 149.3 144.1 129.8 113.9 120.8 91.5 59.1 42.8 31.7 23.2 18.1 13.5 9.4 1.9 9.0 1.1 0.9 0.5 0.8 1.2 3.0 4.1 8.4 8.9 6.8 4.9 5.3 6.7 6.6 3.8 3.2 2.4 2.2 2.4 2.4 2.2 0.2
Selling, General and Administrative Expenses 117.5 121.0 117.0 105.7 96.1 103.3 79.7 52.4 38.6 28.5 20.1 16.0 12.1 8.7 0 0 0 0.9 0.5 0.8 1.2 2.5 3.6 7.3 6.9 4.7 3.1 2.8 3.7 3.8 1.8 2.7 2.1 1.9 2.1 2.1 1.9 0
Research and Development Expenses 27.8 28.3 27.2 24.2 17.8 17.5 11.8 6.7 4.2 3.2 3.0 2.1 1.4 0.7 0 0 0 0 0 0 0 0.4 0.5 0.9 1.1 1.2 1.0 1.5 1.9 1.9 1.4 0 0 0 0 0 0 0
Operating Income (3.3) (21.5) (29.7) (25.4) (23.2) (31.4) (20.5) (8.0) (8.1) (9.3) (9.8) (9.6) (7.8) (7.0) (1.8) 16.0 (1.1) (0.8) (0.4) (0.3) (0.1) (1.2) (2.5) (3.3) (2.9) (1.8) (0.4) 100 K (0.6) 100 K 0.8 0.7 1.2 1.1 0.6 0.7 1.0 0.5
PRE-TAX INCOME
Interest Income Expense 8.2 2.8 0.6 1.4 1.1 40 K 1.2 2.5 6.3 4.1 7.9 5.0 2.4 2.3 2.1 0 0 0 0 0 0 37.8 K 0.1 (8.8) 0 0 0 2.2 0 0 0 0 0 0 100 K 100 K 0 0
Total Other Income (6.7) (0.3) 0.8 (1.6) (0.6) 2.3 (1.9) (2.5) (6.3) (4.1) (7.9) (5.0) (2.4) (2.3) 2.7 1.95 K 16.1 K 50.9 K 61.8 K 0 0 (0.4) (0.1) 4.7 4.3 7.71 K 1.4 0.5 0 100 K 0 100 K 0.2 0.2 100 K 0.2 0.2 0.2
Pre-Tax Income (10.0) (21.7) (28.9) (27.0) (23.8) (29.1) (22.4) (10.4) (14.4) (13.4) (17.7) (14.6) (10.2) (6.9) (1.8) 16.0 0 0 0 (0.3) (0.1) (1.3) (2.6) 1.4 (2.9) (1.7) (0.4) 100 K (0.6) 0 0.8 0.9 1.4 1.3 0.5 0.9 1.2 0.7
NET INCOME
Tax Provision 0 0 (1.6) 1.1 1.0 13 K 0.7 2.5 6.3 4.1 7.9 5.0 (0.7) (0.1) (0.5) 1.0 16.1 K 50.9 K 30.2 K 0.2 1.45 K 3 K 25.5 K 48 K 38.9 K (0.2) 100 K 4.6 100 K (0.3) 0.2 0.2 0.4 0.4 100 K 0.3 0.3 0.2
Net Income (10.0) (21.7) (27.3) (28.1) (24.8) (29.1) (22.4) (10.4) (14.4) (13.4) (17.7) (14.6) (9.4) (9.2) (1.3) 15.0 (1.0) (0.7) (0.4) (0.5) 2.3 (1.3) (2.6) 1.3 (2.9) (1.7) (0.4) (2.3) (0.6) 0.2 0.6 0.7 1.0 0.9 0.4 0.6 0.9 0.5
EPS 0.23 0.51 0.65 0.68 0.62 0.74 0.6 0.31 0.47 0.51 1 1.08 0.85 2.49 1.57 3.51 0.24 0.18 0.0885 0.13 0.57 0.32 0.66 0.34 0.74 0.43 0.0999 0.6 0.16 0.0523 0.17 0.2 0.26 0.26 0.11 0.17 0.26 0.18